Tyligand Bioscience and Context Therapeutics Sign Strategic Development Agreement for Onapristone ER Read more
Vir Biotechnology Announces Intent to Collaborate with Biogen on Manufacturing of Antibodies to Potentially Treat COVID-19 Read more
Emergent BioSolutions Initiates Development of Plasma-Derived Product Candidates for the Treatment and Prevention of Coronavirus Disease Read more
Harbour BioMed Raises $75 Million Series B+ Venture Capital Financing To Accelerate Its Innovative Pipeline Read more
Kuur Therapeutics launches to develop and commercialise off-the-shelf CAR-NKT cell therapies Read more
Chime Biologics Evolving Into One of the Leading CDMOs in China Serving the Global Biotech Industry Read more